Vascular endothelial growth factor - Structure, function and role in airways inflammation and the clinical course of asthma;Czynnik wzrostu śródbłonka naczyniowego - Struktura, funkcje oraz rola w zapaleniu oskrzeli i przebiegu klinicznym astmy

Pneumonologia i Alergologia Polska

Volumn 77, Issue 6, 2009, Pages 549-553

  Gomułka, Krzysztof ^a   Liebhart, Jerzy ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Angiogenesis; Bronchial asthma; Remodeling; Vascular endothelial growth factor

Indexed keywords

VASCULOTROPIN A;

ANIMAL; ASTHMA; BLOOD; BRONCHITIS; CHEMISTRY; HUMAN; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); REVIEW;

ANIMALS; ASTHMA; BRONCHITIS; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77949329188     PISSN: 08677077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Global strategy for asthma management and prevention. National Institutes of Health Publication. GINA Executive and Science Committees. Updated 2008. www.ginasthma.com; epub. Jan 2009.
2. Cohn L., Elias J., Chupp G. Asthma: mechanisms of disease persistence and progression. Annu. Rev. Immunol. 2004; 22: 789-815.
3. James A. Airway remodeling in astma. Curr. Opin. Pulm. Med. 2005; 11: 1-6.
4. Ferrara N., Gerber H. The role of vascular endothelial growth factor in angiogenesis. Acta Haematol. 2001; 106: 148-156.
5. Patan S. Vasculogenesis and angiogenesis. Cancer Treat. Res. 2004; 117: 3-32.
6. Ribatti D. The crucial role of vascular permeability factor/vascular endothelial growth factor in angiogenesis: a historical review. Br. J. Haematology. 2005; 128 (3): 303-309.
7. Neagoe P., Lemieux C., Sirois M. Vascular endothelial growth factor (VEGF)-A165-induced prostacyclin synthesis requires the activation of VEGF receptor-1 and-2 heterodimer. J. Biol. Chem. 2005; 280: 9904-9912.
8. Voelkel N., Vandivier R., Tuder R. Vascular endothelial growth factor in the lung. Am. J. Physiol. Lung. Cell. Mol. Physiol. 2006; 290: 209-221.
9. Świdzińska E., Ossoliński M., Naumnik W., Izycki T., Kucejko W., Chyczewska E. Naczyniowo-śródbłonkowy czynnik wzrostu-VEGF i rozpuszczalny receptor sVEGFR-1 w surowicy chorych na raka płuca. Pneum. Alergol. Pol. 2004; 72: 9-10.
10. Łojko A., Komarnicki M. Naczyniowo-śródbłonkowy czynnik wzrostu a angiogeneza w chorobach nowotworowych. Współcz. Onkol. 2004; 8: 1-4.
11. Feltis B., Wignarajah D., Zheng L. i wsp. Increased vascular endothelial growth factor and receptors: relationship to angiogenesis in asthma. Am. J. Respir. Crit. Care. Med. 2006; 173: 1201-1207.
12. Rovina N., Papapetropoulos A., Kollintza A. i wsp. Vascular endothelial growth factor: an angiogenic factor reflecting airway inflammation in healthy smokers and in patients with bronchitis type of chronic obstructive pulmonary disease? Respir. Res. 2007; 8: 53.
13. Doherty T., Broide D. Cytokines and growth factors in airway remodeling in asthma. Curr. Opin. Immunol. 2007; 19: 676-680.
14. Avdalovic M., Putney L., Schelegle E. i wsp. Vascular remodeling is airway generation-specific in a primate model of chronic asthma. Am. J. Respir. Crit. Care. Med. 2006; 174: 1069-1076.
15. Feistritzer C., Kaneider N., Sturn D., Mosheimer B., Kähler C., Wiedermann C. Expression and function of the vascular endothelial growth factor receptor FLT-1 in human eosinophils. Am. J. Respir. Cell. Mol. Biol. 2004; 30: 729-735.
16. Kristan S.S., Malovrh M.M., Silar M. i wsp. Airway angiogenesis in patients with rhinitis and controlled asthma. Clin. Exp. Allergy 2009; 39: 354-360.
17. Brown J.L., Behndig A.F., Sekerel B.E. i wsp. Lower airways inflammation in allergic rhinitis: a comparison with asthmatics and normal controls. Clin. Exp. Allergy. 2007; 37: 688-695.
18. Kanazawa H. Role of vascular endothelial growth factor in the pathogenesis of chronic obstructive pulmonary disease. Med. Sci. Monit. 2007; 13: 189-195.
19. Verhoeckx K., Doornbos R., Witkamp R., van der Greef J., Rodenburg R. Beta-adrenergic receptor agonists induce the release of granulocyte chemotactic protein-2, oncostatin M and vascular endothelial growth factor from macrophages. Int. Immunopharmacol. 2006; 6: 1-7.
20. Lee K., Lee K., Park S. i wsp. Clinical significance of plasma and serum vascular endothelial growth factor in asthma. J. Asthma. 2008; 45: 735-739.
21. Abdel-Rahman A., El-Sahrigy S., Bakr S. A comparative study of two angiogenic factors: vascular endothelial growth factor and angiogenin in induced sputum from asthmatic children in acute attack. Chest. 2006; 129: 266-271.
22. Lee C., Link H., Baluk P. Vascular endothelial growth factor (VEGF) induces remodeling and enhaces Th2-mediated sensitization and inflammation in the lung. Nature. 2005; 116: 556-557.
23. Feltis B., Wignarajah D., Reid D., Ward C., Harding R., Walters E. Effects of inhaled fluticasone on angiogenesis and vascular endothelial growth factor in asthma. Thorax 2007; 62: 283-285.
24. Lee K., Kim S., Park S. i wsp. Mast cells can mediate vascular permeability through regulation of PI3K-HIF-1{alpha}-VEGF axis. Am. J. Respir. Crit. Care. Med. 2008; 178: 787-797.
25. Hoshino M., Takahashi M., Aoike N. Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. J. Allergy. Clin. Immunol. 2001; 107: 295-301.
26. Lee K., Park S., Kim S. i wsp. Inhibition of VEGF blocks TGF--beta1 production through a PI3K/Akt signalling pathway. Eur. Respir. J. 2008; 31: 523-531.
27. Broide D. Immunologic and inflammatory mechanisms that drive asthma progression to remodeling. J. Allergy. Clin. Immunol. 2008; 121: 560-570.
28. Vignola A., Mirabella F., Constanzo G., Di Gorgi R. Airway remodeling in asthma. Chest 2003; 123 (supl. 3): 417-422.
29. Siddiqui S., Sutcliffe A., Shikotra A. i wsp. Vascular remodeling is a feature of asthma and nonasthmatic eosinophilic bronchitis. J. Allergy. Clin. Immunol. 2007; 120: 813-819.
30. Papaioannou A., Kostikas K., Kolia P., Gourgoulianis K. Clinical implications for Vascular Endothelial Growth Factor in the lung: friend or foe? Respir. Res. 2006; 7: 128.
31. Makinde T., Murphy R., Agrawal D. Immunomodulatory role of vascular endothelial growth factor and angiopoietin-1 in airway remodeling. Curr. Mol. Med. 2006; 6: 831-841.
32. Su X., Taniuchi N., Jin E. i wsp. Spatial and phenotypic characterization of vascular remodeling in a mouse model of asthma. Pathobiolog. 2008; 75: 42-56.
33. Hossny E., El-Awady H., Bakr S., Labib A. Vascular endothelial growth factor overexpression in induced sputum of children with bronchial asthma. Pediatr. Allergy. Immunol. 2008; 19: 13-19.
34. Faffe D., Flynt L., Bourgeois K., Panettieri R., Shore S. Interleukin-13 and Interleukin-4 induce vascular endothelial growth factor release from airway smooth muscle cells. Am. J. Res. Cell. Mol. Biol. 2006; 34: 213-218.
35. Simcock D., Kanabar V., Clarke G. i wsp. Induction of angiogenesis by airway smooth muscle from patients with asthma. Am. J. Respir. Crit. Care. Med. 2008; 178: 460-468.
36. Lee K., Park S., Kim S. i wsp. Inhibition of VEGF blocks TGF--beta1 production through a PI3K/Akt signalling pathway. Eur. Respir. J. 2008; 31: 523-531.
37. Sharma S., Murphy A.J., Soto-Quiros M.E. i wsp. Association of vascular endothelial growth factor polymorphisms with childhood asthma, lung function, and airways responsiveness. Eur. Respir. J. 2009; 33: 1287-1294.
38. Sun Y., Wang J., Li H., Han X. Found in inflammatory zone 1 induces angiogenesis in murine models of asthma. Lung 2008; 186: 375-380.
39. Yamaji-Kegan K., Su Q., Angelini D.J., Johns R.A. IL-4 is proangiogenic in the lung under hypoxic conditions. J. Immunol. 2009; 182: 5469-5476.